Sign inJoin waitlistJoin the waitlist

SH

Shernan Holtan

Physician · Roswell Park Comprehensive Cancer Center

Credentials: · · · ·

History

Roswell Park Comprehensive Cancer Center
2024–Present

Hematology
2006–2007
Internal Medicine
2003–2006
Univ of Nebraska Coll of Med
1999–2003

Research

Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis
New England Journal of Medicine · 2023 · 550 citations
Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation
Blood · 2015 · First of 9 authors · 461 citations
A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality
Biology of Blood and Marrow Transplantation · 2015 · 249 citations

Daniel Weisdorf
89 papers
Armin Rashidi
49 papers · 3 as a fellow
Margaret MacMillan
49 papers
Bruce Blazar
36 papers
MA
Mukta Arora
34 papers
Najla El Jurdi
32 papers
Alexander Khoruts
27 papers
BB
Brian Betts
27 papers
Claudio Brunstein
24 papers
Tauseef Rehman
17 papers
LN
Laura Newell
16 papers
Svetomir Markovic
16 papers

Grants

BMT CTN Core - University of Minnesota
National Heart, Lung, and Blood Institute · UG1
Contact PI · $184.8K · University of Minnesota
2001–2024

Clinical trials

Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Principal investigator · Recruiting · Phase 1
Roswell Park Cancer Institute
2026–2028
Improving Self-Efficacy, Resolving Inflammaging Allo HSCT Survivors in Personal Training
Principal investigator · Completed
Masonic Cancer Center, University of Minnesota
2018–2021
Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD
Principal investigator · Completed · Phase 1, Phase 2
Masonic Cancer Center, University of Minnesota
2016–2022